Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teprenone plus folic acid chemoprevention after Helicobacter pylori eradication for intestinal metaplasia
ChiCTR-OPN-16009228Phase 4Completed
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of teprenone and folic acid in Intestinal metaplasia and Helicobacter pylori infection (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: Intestinal metaplasia scores. Started Feb 2006; status: completed.
02
Drugs
teprenonefolic acid
03
Conditions
Intestinal metaplasiaHelicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR-OPN-16009228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16009228.